×

OmniComm Systems, Inc. Appoints Kuno van der Post, Ph.D. as Senior Vice President of Business Development

company logo

FORT LAUDERDALE, Fla., June 24, 2013 (GLOBE NEWSWIRE) -- OmniComm Systems, Inc. (OTC:OMCM.OB), one of the fastest growing companies in the EDC marketplace, today announced that Kuno van der Post, Ph.D. has been promoted to Senior Vice President of Business Development.

Mr. van der Post, who was most recently OmniComm's Vice President of Business Development managing the Southeast region of the U.S., will oversee all of OmniComm's global sales and marketing responsibilities and report directly to Stephen Johnson, President & Chief Operating Officer. "After a rigorous interview process which included candidates from within and outside of OmniComm, we are confident that we have the right person for the job," said Mr. Johnson. "Kuno has a strong scientific sales background with extensive industry experience and will without doubt lead by example. His vision for the eClinical future aligns perfectly with our corporate strategy and we expect great things from Kuno in his new role."

Mr. van der Post joined OmniComm Systems, Inc. in September of 2012 as VP of Business Development. He was instrumental in closing 2 very large contracts in his first 7 months and was also responsible for the creation of OmniComm's formal Channel Partner's Program. Mr. van der Post has 17 years of industry experience and had previously worked for the two largest vendors in the industry, Oracle and Medidata. Prior to joining OmniComm, Kuno spent 3 years at Oracle managing their Channel Partners Program in both Europe and Latin America. He also spent 3 years at Medidata as Area Sales Director for their Northern European region.

"Having worked extensively with the 3 EDC solutions offered by both Oracle and Medidata, I am very excited to be at OmniComm," said Mr. van der Post. "The high quality of customer support coupled with their significant investment in new product development is already offering the market the next generation of EDC with time and cost saving functionality that is currently unmatched."

About OmniComm

OmniComm Systems, Inc. (www.OmniComm.com) provides customer-driven Internet solutions to pharmaceutical, biotechnology, research and medical device organizations that conduct life changing clinical trial research. OmniComm's growing base of satisfied customers is a direct result of the company's commitment to deliver products and services that ensure ease of use, faster study build, ease of integration and better performance. OmniComm's pricing model is easily understood and allows companies ranging from small, to large, to maximize their clinical research investments. OmniComm Systems, Inc. has U.S. headquarters in Fort Lauderdale, FL and European headquarters in Bonn, Germany, with satellite offices in New Jersey and the United Kingdom, as well as sales offices throughout the U.S. and Europe.

Safe Harbor Disclaimer

Statements made by OmniComm included in this release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements involve a number of risks and uncertainties such as the Company's ability to obtain new contracts and accurately estimate net revenues due to uncertain regulatory guidance, variability in size, scope and duration of projects, and internal issues at the sponsoring client, integration of acquisitions, competitive factors, technological development, and market demand. As a result, actual results may differ materially from any financial outlooks stated herein. Further information on potential factors that could affect the Company's financial results can be found in the Company's Reports on Form 10-K and 10-Q filed with the Securities and Exchange Commission. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise.

CONTACT: Stephen Johnson OmniComm Systems, Inc. 954-473-1254 sjohnson@omnicomm.com

Source:OmniComm Systems Inc.